Adial Pharmaceuticals Inc (ADIL)

09:33 AM

Adial Pharmaceuticals Stock Faces Crucial AD04 Funding Test After Holiday Break - Bez Kabli

09:33 AM

May 25, 2026

Adial Pharmaceuticals (ADIL) Drops 9.57% as Selling Pressure Mounts Near Key SupportShakeout Pattern - Newser

May 25, 2026

May 23, 2026

ADIL Q1 2026 Earnings: Narrowed Loss Beats Estimates, but Market Remains CautiousSocial Flow Trades - Newser

May 23, 2026

May 22, 2026

ADIL Q1 2026 Earnings: Narrowing Loss Beats Estimates, But Stock Declines Amid No RevenuePost-Earnings Reaction - Newser

May 22, 2026

May 19, 2026

Adial Pharmaceuticals lead drug fits new policy mood as bipartisan bill signals broader lens on alcohol use disorder - MSN

May 19, 2026

May 19, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

May 19, 2026

May 19, 2026

Why Is Adial Pharmaceuticals, Inc. (ADIL) Stock Down Today? - Meyka

May 19, 2026

May 18, 2026

Why Is Adial Pharmaceuticals, Inc. WT EXP 073123 (ADILW) Stock Up Today? - Meyka

May 18, 2026

May 15, 2026

Armistice Capital/Steven Boyd report 4.99% stake in Adial (NASDAQ: ADIL) - Stock Titan

May 15, 2026

May 15, 2026

ADIL Should I Buy - Intellectia AI

May 15, 2026

May 13, 2026

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 13, 2026

May 12, 2026

Adial Pharmaceuticals 1Q Loss $2M >ADIL - Moomoo

May 12, 2026

May 12, 2026

The quiet strength in Adial Pharma (ADIL) business model (+4.20%) 2026-05-11Community Chart Signals - Newser

May 12, 2026

May 11, 2026

Adial Pharmaceuticals: Runway to Fund Operating Expenses Into 2nd Half of 2026 >ADIL - Moomoo

May 11, 2026

May 11, 2026

Adial Pharmaceuticals Q1 Net Income USD2 Million - TradingView

May 11, 2026

May 11, 2026

Adial Pharmaceuticals Reports Q1 2026 Results, Advances AD04 for Alcohol Use Disorder with FDA and European Developments 12 - Minichart

May 11, 2026

May 11, 2026

Adial Pharmaceuticals (NASDAQ: ADIL) details evolving AD04 development and IP - Stock Titan

May 11, 2026

May 11, 2026

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update - ChartMill

May 11, 2026

May 09, 2026

Adial Pharmaceuticals Q1 2026 10-Q Report: Clinical Development of AD04 for Alcohol Use Disorder, Financial Results, and Liquidity Update - Minichart

May 09, 2026

May 08, 2026

Adial Pharmaceuticals Inc (ADIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 08, 2026

May 08, 2026

Adial Pharmaceuticals Inc expected to post a loss of $1.21 a shareEarnings Preview - TradingView

May 08, 2026

May 08, 2026

Adial Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

Adial (NASDAQ: ADIL) flags going concern risk while advancing AD04 partnership plans - Stock Titan

May 08, 2026

May 08, 2026

ADIL Price Today: Adial Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

May 08, 2026

May 08, 2026

The quiet positioning of Adial Pharma (ADIL) nobody discusses (-10.13%) 2026-05-08Value ETF - Newser

May 08, 2026

May 03, 2026

EBIT per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView

May 03, 2026

Apr 30, 2026

ADIL Stock Price, Quote & Chart | ADIAL PHARMACEUTICALS INC (NASDAQ:ADIL) - ChartMill

Apr 30, 2026

Apr 29, 2026

Adial Pharmaceuticals files patent application for AD04 By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals files patent application for AD04 - Investing.com

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 - The Manila Times

Apr 29, 2026

Apr 29, 2026

Adial seeks U.S. patent that could protect its lead alcohol-use drug to 2045 - Stock Titan

Apr 29, 2026

Apr 29, 2026

Adial Pharmaceuticals Files New U.S. Utility Patent Application For AD04 Targeting Alcohol Use Disorder - marketscreener.com

Apr 29, 2026

Apr 28, 2026

Exclusive: Adial Pharmaceuticals clears manufacturing milestone ahead of pivotal study for alcohol use disorder drug - MSN

Apr 28, 2026

Apr 27, 2026

Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN

Apr 27, 2026

Apr 27, 2026

Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight - GlobeNewswire Inc.

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals (ADIL) Submits Application to FDA's National Priority Voucher Program - GuruFocus

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals applies for FDA priority voucher program - Investing.com

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals applies for FDA priority voucher program By Investing.com - Investing.com India

Apr 27, 2026

Apr 27, 2026

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program - The Manila Times

Apr 27, 2026

Apr 25, 2026

Adial Pharmaceuticals (ADIL) price target decreased by 10.26% to 23.80 - MSN

Apr 25, 2026

Apr 23, 2026

EXCLUSIVE: Adial Pharmaceuticals Clears Manufacturing Milestone Ahead Of Pivotal Study For Alcohol Use Disorder Drug - Sahm

Apr 23, 2026

Apr 22, 2026

Adial Pharmaceuticals completes AD04 demonstration batch production By Investing.com - Investing.com Australia

Apr 22, 2026

Apr 22, 2026

ADIL (Adial Pharmaceuticals Inc) reports wider than expected Q4 2025 loss, yet stock notches 2.53 percent gain today.Quick Ratio - UBND thành phố Hải Phòng

Apr 22, 2026